Board approved year-end financial results: Profit 15.65 Cr (standalone), 13.75 Cr (consolidated); Revenue 870.32 Cr.

Proposed Rs.0.25/share dividend.

MD Sri S V Arumugam re-appointed for 3 years.

Forfeited 42.26 lakh share warrants (upfront 6.55 Cr) due to non-conversion.

Company is now an associate, not a subsidiary.